These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 32919119

  • 1. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors.
    Mohan S, Patel S, Barlow D, Rojas AC.
    Adv Med Sci; 2020 Sep; 65(2):424-428. PubMed ID: 32919119
    [Abstract] [Full Text] [Related]

  • 2. Assessing N w-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker.
    Mohan S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D.
    Amino Acids; 2018 Apr; 50(3-4):373-382. PubMed ID: 29260322
    [Abstract] [Full Text] [Related]

  • 3. Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells.
    Mohan S, Patel S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D.
    Amino Acids; 2018 Nov; 50(11):1629-1636. PubMed ID: 29922922
    [Abstract] [Full Text] [Related]

  • 4. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
    Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, Martin DN, Switzer CH, Hudson RS, Wink DA, Lee DH, Stephens RM, Ambs S.
    J Clin Invest; 2010 Nov; 120(11):3843-54. PubMed ID: 20978357
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. N w-hydroxy-L-arginine as a novel ethnic specific indicator of estrogen-negative breast cancer.
    Mohan S, Moua N, Harding L.
    Amino Acids; 2016 Nov; 48(11):2693-2698. PubMed ID: 27503558
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells.
    López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, Conde F, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A.
    Lab Invest; 2021 Mar; 101(3):292-303. PubMed ID: 33262438
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
    Basudhar D, Somasundaram V, de Oliveira GA, Kesarwala A, Heinecke JL, Cheng RY, Glynn SA, Ambs S, Wink DA, Ridnour LA.
    Antioxid Redox Signal; 2017 Jun 20; 26(18):1044-1058. PubMed ID: 27464521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
    Burke AJ, Garrido P, Johnson C, Sullivan FJ, Glynn SA.
    Antioxid Redox Signal; 2017 Jun 20; 26(18):1078-1090. PubMed ID: 28326819
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line.
    Oktem G, Bilir A, Selvi N, Yurtseven ME, Vatansever S, Ates U, Uysal A, Omay SB.
    Oncol Res; 2006 Jun 20; 16(4):195-203. PubMed ID: 17120617
    [Abstract] [Full Text] [Related]

  • 16. NOS2 as an Emergent Player in Progression of Cancer.
    Thomas DD, Wink DA.
    Antioxid Redox Signal; 2017 Jun 10; 26(17):963-965. PubMed ID: 28506076
    [Abstract] [Full Text] [Related]

  • 17. Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
    Llaurado Fernandez M, Dawson A, Kim H, Lam N, Russell H, Bruce M, Bittner M, Hoenisch J, Scott SA, Talhouk A, Chiu D, Provencher D, Nourmoussavi M, DiMattia G, Lee CH, Gilks CB, Köbel M, Carey MS.
    Gynecol Oncol; 2020 Apr 10; 157(1):12-20. PubMed ID: 31954537
    [Abstract] [Full Text] [Related]

  • 18. Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures.
    Meng P, Vaapil M, Tagmount A, Loguinov A, Vulpe C, Yaswen P.
    Breast Cancer Res Treat; 2019 Jul 10; 176(1):131-140. PubMed ID: 30993572
    [Abstract] [Full Text] [Related]

  • 19. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM, Korach KS.
    Mol Endocrinol; 2003 May 10; 17(5):792-803. PubMed ID: 12586845
    [Abstract] [Full Text] [Related]

  • 20. Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
    Wartenberg M, Schallenberg M, Hescheler J, Sauer H.
    Int J Cancer; 2003 Apr 10; 104(3):274-82. PubMed ID: 12569550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.